Gilead Sciences, Inc. Dividend History (GILD)
Gilead Sciences, Inc. will distribute a dividend of $0.77 per share on December 30, 2024 (20 days)
🤑 Gilead Sciences, Inc. has distributed a total of 38 dividends from 2015 to 2024
📈 During this 9 period their dividend has seen a 79.07% increase in the payout amount
About Gilead Sciences, Inc.
Gilead Sciences, Inc. is a biopharmaceutical company founded in 1987, headquartered in Foster City, California. It's known for its research and development in antiviral drugs, particularly those used in the treatment of HIV, hepatitis B, hepatitis C, and influenza. Gilead played a significant role during the COVID-19 pandemic with its antiviral medication, remdesivir. As of now, the CEO is Daniel O’Day, who took the helm in 2019. The company is widely recognized for its innovative approach in tackling complex health challenges and aims to improve patient care worldwide. In 2022, Gilead's revenue was approximately $27 billion, reflecting its strong market presence and the critical nature of its therapies.
AbbVie Inc.
Ligand Pharmaceuticals Incorporated
Merck & Co., Inc.
Moderna, Inc.
Pfizer Inc.
Vertex Pharmaceuticals Incorporated
Vir Biotechnology, Inc.
The cancer monoclonal antibodies market is projected to grow at a CAGR of 18.4% to reach $337.92 billion by 2031, driven by the high incidence of cancer and advancements in biotechnology. The rising use of combination therapies and biosimilars is also expected to create new opportunities for companies in this market.
Benzinga · Published on Mon Dec 09 2024The global coccidioidomycosis drugs market is expected to grow at a CAGR of 4.9% and reach a valuation of US$ 634.3 million by 2034, driven by increased awareness, development in antifungals, and improved access to healthcare in endemic regions.
GlobeNewswire Inc. · Published on Wed Dec 04 2024The global personalized medicines market is expected to reach a value of USD 1352.81 Billion by 2031, driven by the growing demand for innovative therapies and advancements in genetic technology. The market is dominated by hospitals and clinical care, and North America leads the market due to favorable regulatory frameworks.
Benzinga · Published on Wed Nov 27 2024Previous Payouts (38)
The most recent dividend Gilead Sciences, Inc. paid out was on September 27, 2024 (74 days ago) for $0.77 per share
| Pay Date | Amount |
|---|---|
| September 27, 2024 | $0.77 |
| June 27, 2024 | $0.77 |
| March 28, 2024 | $0.77 |
| December 28, 2023 | $0.75 |
| September 28, 2023 | $0.75 |
| June 29, 2023 | $0.75 |
| March 30, 2023 | $0.75 |
| December 29, 2022 | $0.73 |
| September 29, 2022 | $0.73 |
| June 29, 2022 | $0.73 |
| March 30, 2022 | $0.73 |
| December 30, 2021 | $0.71 |
| September 29, 2021 | $0.71 |
| June 29, 2021 | $0.71 |
| March 30, 2021 | $0.71 |
| December 30, 2020 | $0.68 |
| September 29, 2020 | $0.68 |
| June 29, 2020 | $0.68 |
| March 30, 2020 | $0.68 |
| December 30, 2019 | $0.63 |
| September 27, 2019 | $0.63 |
| June 27, 2019 | $0.63 |
| March 28, 2019 | $0.63 |
| December 28, 2018 | $0.57 |
| September 27, 2018 | $0.57 |
| June 28, 2018 | $0.57 |
| March 29, 2018 | $0.57 |
| December 28, 2017 | $0.52 |
| September 28, 2017 | $0.52 |
| June 29, 2017 | $0.52 |
| March 30, 2017 | $0.52 |
| December 29, 2016 | $0.47 |
| September 29, 2016 | $0.47 |
| June 29, 2016 | $0.47 |
| March 30, 2016 | $0.43 |
| December 30, 2015 | $0.43 |
| September 29, 2015 | $0.43 |
| June 29, 2015 | $0.43 |
Dividend data last updated Tue, 10 Dec 2024 13:27:44 GMT UTC